Approval · Notice of Compliance 153 · 2004
NORPROLAC: Notice of Compliance 153
Issued March 15, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 153
- Date
- March 15, 2004
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Prolactin inhibitor
Products in this notice
Medicinal ingredients
- QUINAGOLIDE HCL 0.025 MG per TAB
- QUINAGOLIDE HCL 0.05 MG per TAB
- QUINAGOLIDE HCL 0.075 MG per TAB
- QUINAGOLIDE HCL 0.15 MG per TAB